Swiss - Delayed Quote
CHF
Galderma Group AG (GALD.SW)
192.85
+3.15
(+1.66%)
At close: October 30 at 5:30:30 PM GMT+1
Earnings Trends
Earnings Per Share (GAAP)
Revenue vs. Earnings
Q3 FY26
Revenue
1.63B
Earnings
--
Profit Margin
0.00%
Q4
FY25
Q1
FY26
Q2
FY26
Q3
FY26
0
500M
1B
2B
0.0%
Revenue Estimate
| Currency in USD
|
Current Qtr. (Sep 2026)
|
Next Qtr. (Dec 2026)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
No. of Analysts
|
3 | 1 | 15 | 16 |
|
Avg. Estimate
|
1.55B | 1.74B | 6.46B | 7.67B |
|
Low Estimate
|
1.53B | 1.74B | 6.36B | 7.49B |
|
High Estimate
|
1.57B | 1.74B | 6.55B | 8.09B |
|
Year Ago Sales
|
1.29B | 1.47B | 5.21B | 6.46B |
|
Sales Growth (year/est)
|
20.48% | 18.11% | 24.07% | 18.79% |
Earnings Estimate
| Currency in USD
|
Current Qtr. (Sep 2026)
|
Next Qtr. (Dec 2026)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
No. of Analysts
|
-- | -- | -- | 15 |
|
Avg. Estimate
|
-- | -- | -- | 6.69 |
|
Low Estimate
|
-- | -- | -- | 6.69 |
|
High Estimate
|
-- | -- | -- | 7.06 |
|
Year Ago EPS
|
-- | -- | -- | 4.79 |
Earnings History
EPS Trend
| Currency in USD
|
Current Qtr. (Sep 2026)
|
Next Qtr. (Dec 2026)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
Current Estimate
|
-- | -- | -- | 6.69 |
|
7 Days Ago
|
-- | -- | -- | 6.32 |
|
30 Days Ago
|
-- | -- | -- | 6.33 |
|
60 Days Ago
|
-- | -- | -- | 6.33 |
|
90 Days Ago
|
-- | -- | -- | 6.33 |
EPS Revisions
| Currency in USD
|
Current Qtr. (Sep 2026)
|
Next Qtr. (Dec 2026)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
Up Last 7 Days
|
-- | -- | -- | 1 |
|
Up Last 30 Days
|
-- | -- | -- | 5 |
|
Down Last 7 Days
|
-- | -- | -- | 1 |
|
Down Last 30 Days
|
-- | -- | -- | 2 |
Growth Estimates
| Symbol | Current Qtr. | Next Qtr. | Current Year | Next Year |
|---|---|---|---|---|
|
GALD.SW
|
-- | -- | 29.92% | 39.55% |
|
S&P 500
|
25.73% | 27.39% | 33.08% | 16.55% |
